Who owns Lipocine?

Top Holders and Investors of Lipocine Stock

Find out what company owns Lipocine, who bought Lipocine this quarter, and who sold shares of Lipocine stock?

Fund or Company Name Number of Shares Valued At As Of
Ameriprise Financial 702400 $1.62M Mar 2019
Vanguard 480623 $1.08M Mar 2019
Renaissance Technologies 406700 $939477 Mar 2019
BlackRock 310661 $714520 Mar 2019
Mercer Global Advisors 212203 $490188 Mar 2019
Geode Capital Management 177263 $409477 Mar 2019
Dimensional Fund Advisors 143667 $331870 Mar 2019
Spark Investment Management 51103 $118047 Mar 2019
Northern Trust 50817 $116879 Mar 2019
Knoll Capital Management 50000 $116000 Mar 2019
Deutsche Bank Aktiengesellschaft 48600 $111780 Mar 2019
CalPERS 46000 $105800 Mar 2019
Susquehanna International 34999 $80847 Mar 2019
Citadel Advisors 29450 $68324 Mar 2019
PanAgora Asset Management 22684 $51946 Mar 2019
Acadian Asset Management 17956 $40939 Mar 2019
Jpmorgan Chase & Co 16200 $36936 Mar 2019
Two Sigma Investments 14626 $33932 Mar 2019
Group One Trading 14140 $32946 Mar 2019
Bank of New York Mellon 14128 $32635 Mar 2019
Cutler 13000 $30030 Mar 2019
State Street Corporation 12400 $29016 Mar 2019
Ladenburg Thalmann Financial Services 6650 $15029 Mar 2019
Meeder Asset Management 3408 $8008 Mar 2019
UBS Group AG 3235 $6987 Mar 2019
Morgan Stanley 2250 $4995 Mar 2019
Benjamin F. Edwards & Company 1500 $3000 Mar 2019
Advisor 1150 $3001 Mar 2019
Bank of America Corporation 1000 $2000 Mar 2019
Federated Investors 633 $1000 Mar 2019
Simplex Trading 432 $0 Mar 2019
Bnp Paribas Arbitrage, Snc 4 $9 Mar 2019

Who sold Lipocine?

Fund Name Date Sold Shares Held Valued At
J. Goldman & Co Dec. 31, 2018 238428 $309956
Barclays Dec. 31, 2018 30200 $38958
Macquarie Dec. 31, 2018 2300 $2990